<
https://theconversation.com/how-a-century-old-drug-could-revolutionise-cobra-bite-treatment-234277>
"About 1.8 million people worldwide are bitten by snakes each year. Of those,
up to 138,000 die and another 400,000 end up with permanent scarring and
disability.
Many cobras have tissue-damaging venoms that can’t be treated with current
antivenoms. We have discovered that cheap, readily available blood-thinning
medications can be repurposed as antidotes for these venoms.
Using CRISPR gene-editing technology we learned more about how these venoms
attack our cells, and found out that a common class of drugs called heparinoids
can protect tissue from the venom. Our research is published today in
Science
Translational Medicine."
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
